Liver Diseases, Alcoholic

"Liver Diseases, Alcoholic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS.

Descriptor ID	D008108
MeSH Number(s)	C06.552.645 C25.775.100.087.645
Concept/Terms	Liver Diseases, Alcoholic Liver Diseases, Alcoholic Alcoholic Liver Diseases Alcoholic Liver Disease Liver Disease, Alcoholic

Below are MeSH descriptors whose meaning is more general than "Liver Diseases, Alcoholic".

Diseases [C]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Liver Diseases, Alcoholic [C06.552.645]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Alcohol-Related Disorders [C25.775.100]
Alcohol-Induced Disorders [C25.775.100.087]
Liver Diseases, Alcoholic [C25.775.100.087.645]

Below are MeSH descriptors whose meaning is more specific than "Liver Diseases, Alcoholic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Diseases, Alcoholic" by people in this website by year, and whether "Liver Diseases, Alcoholic" was a major or minor topic of these publications.

Bar chart showing 67 publications over 22 distinct years, with a maximum of 8 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2005	1	1	2
2007	1	0	1
2008	1	0	1
2009	1	0	1
2010	3	0	3
2011	5	0	5
2012	2	0	2
2013	3	1	4
2014	1	0	1
2015	1	4	5
2016	2	0	2
2017	5	0	5
2018	5	0	5
2019	8	0	8
2020	2	1	3
2021	1	0	1
2022	2	0	2
2023	1	0	1
2024	7	0	7
2025	6	0	6
2026	1	0	1

Below are the most recent publications written about "Liver Diseases, Alcoholic" by people in Profiles.

Babuta M, Datta AA, de Carvalho Ribeiro M, Santos BACD, Morel C, Copeland C, Ortega-Ribera M, Mehta J, Calenda C, Wang Y, Remotti V, Brezani V, Patel A, Hawryluk D, Szabo G. Cyclic GMP-AMP synthase deficiency predisposes the liver to alcohol-induced cell death and ER stress. Hepatol Commun. 2026 Mar 01; 10(3).

View in: PubMed
Cooper KM, Patel AK, Colletta A, Mohamed K, Lim N, Wu W, Rajan A, Cheung A, Hasjim BJ, Tesfai K, Ajmera V, Wang K, Deutsch-Link S, Shroff H, Kwong AJ, Devuni D. Gender disparity in access to early liver transplant among patients with alcohol associated liver disease and limited sobriety is mediated by psychosocial factors. Liver Transpl. 2026 Mar 01; 32(3):388-399.

View in: PubMed
Diaz LA, Thiele M, Louvet A, Lee BP, Ajmera V, Tavaglione F, Hsu CL, Huang DQ, Pose E, Bataller R, McClain C, Mellinger J, Tincopa M, Mitchell MC, Ratziu V, Rinella ME, Sarin SK, Shah VH, Szabo G, Wong VW, Bansal MB, Leggio L, Kamath PS, Krag A, Sanyal AJ, Arrese M, Arab JP, Anstee QM, Mathurin P, Loomba R. Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease. Nat Rev Gastroenterol Hepatol. 2025 Dec; 22(12):866-884.

View in: PubMed
Ekuban FA, Gripshover TC, Ames P, Biswas K, Bolatimi OE, Abramson J, Iyer M, Luo J, Ekuban A, Hwang JY, Park JW, Banerjee M, Watson WH, Wahlang B, Bello D, Schlezinger JJ, McClain CJ, Cave MC. Perfluorooctane sulfonate exposure and alcohol-associated liver disease severity in a mouse chronic-binge ethanol feeding model. Toxicol Sci. 2025 Aug 01; 206(2):388-408.

View in: PubMed
Shen H, Liangpunsakul S, Iwakiri Y, Szabo G, Wang H. Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease. Cell Mol Immunol. 2025 Oct; 22(10):1190-1204.

View in: PubMed
Khan MAS, Song BJ, Wang X, Iqbal S, Szabo G, Chang SL. Neutrophil extracellular traps (NETs) and NETosis in alcohol-associated diseases: A systematic review. Alcohol Clin Exp Res (Hoboken). 2025 Apr; 49(4):697-711.

View in: PubMed
Jiao Q, Liu J, Zhou L, McClements DJ, Liu W, Luo J, Peng S. Lactobacillus extracellular vesicles alleviate alcohol-induced liver injury in mice by regulating gut microbiota and activating the Nrf-2 signaling pathway. Food Funct. 2025 Feb 17; 16(4):1284-1298.

View in: PubMed
Arab JP, D?az LA, Rehm J, Im G, Arrese M, Kamath PS, Lucey MR, Mellinger J, Thiele M, Thursz M, Bataller R, Burton R, Chokshi S, Francque SM, Krag A, Lackner C, Lee BP, Liangpunsakul S, MacClain C, Mandrekar P, Mitchell MC, Morgan MY, Morgan TR, Pose E, Shah VH, Shawcross D, Sheron N, Singal AK, Stefanescu H, Terrault N, Tr?po E, Moreno C, Louvet A, Mathurin P. Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. J Hepatol. 2025 Apr; 82(4):744-756.

View in: PubMed
Nagesh PT, Cho Y, Zhuang Y, Babuta M, Ortega-Ribera M, Joshi R, Brezani V, Patel A, Datta AA, Brezani V, Hsieh YC, Ramos A, Mehta J, Copeland C, Kanata E, Jiang ZG, Vlachos I, Asara J, Szabo G. In vivo Bruton's tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis. Sci Transl Med. 2024 08 07; 16(759):eadg1915.

View in: PubMed
Lee DU, Kwon J, Han J, Chang K, Kolachana S, Bahadur A, Lee KJ, Fan GH, Malik R. The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals. J Clin Gastroenterol. 2024 Aug 01; 58(7):708-717.

View in: PubMed

People

Explore

Similar Concepts

Top Journals